The most frequently mutated genes in the classical CRC progression pathway, namely APC, KRAS, P53, and SMAD4, were previously altered in human colon-derived organoids using CRISPR-Cas9-mediated genome editing [20]. The gene discussed is SMAD4; the disease is colorectal carcinoma.